Comparison of Antibiotic Sensitivity of Prevalent BacteriaIsolated from Urinary Tract Infections in 2002 and 2006 in Urmia, Iran Antibiotic sensitivity and ressistance
Iranian Journal of Pharmaceutical Sciences,
Vol. 5 No. 3 (2009),
1 July 2009
,
Page 135-140
https://doi.org/10.22037/ijps.v5.41208
Abstract
Urine specimens collected from in-patients and out-patients in Urmia Imam Hospital, northwest Iran, were cultured on blood agar and Eosin Methylene Blue agar. Isolated bacteria were identified according to standard microbiological tests and then subjected to sensitivity testing according to routine method of disk agar diffusion technique. Out of 8044 and 10425 urine specimens, 8.7% and 11.9% were identified as having urinary tract infection (UTI) in 2002 and 2006, respectively. The most prevalent bacteria belonged to enterobacteriaceae family and in the case of total susceptibility the upmost resistance was recorded against trimethoprim-sulfamethox-azole (62%) and gentamicin (50%) in 2002, and increased to 69% and 57% in 2006,respectively. The least resistance recorded was to ceftizoxim as 15.6% and 16.8 %in 2002 and 2006, respectively. Antibiotics susceptibility of in-patients wassignificantly lower than that of out-patients and this was more obvious for cephalosporins. Our findings show a remarkably high prevalence of resistance to the majority of commonly used antibiotics in UTIs, with a decreasing trend in their activities which probably is due to the high rate of antibiotics use in Iran as the first reason. Results of the present study underline the need for sensitivity tests prior to antibiotic therapy in UTI, which could help and guide in proper choosing of antibiotics and effective treatment and, therefore, prevention of antibiotic resistance.
- Antibiotic resistance
- Antimicrobial susceptibility
- Urinary tract infection
How to Cite
References
[2]Kim ME, Ha US, Cho YH. Prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: Amulticentre study in 2006.Int J Antimicrob Agents2008; 31:15-8.
[3]Astal Z. Increasing ciprofloxacin resistance among prevalent urinary tract bacterial isolates in the Gaza Strip.J Biomed and Biotechnol2005; 3:238-41.
[4]Clinical and laboratory standards institute.Performance standards for antimicrobial susceptibility testing. Vol. 22. Pennsylvania: 12th Informational supplement. CLSI document M100-S12. 2002; No. 1.
[5]Marrs CF, Zhang L, Foxman B. Escherichia coli mediated urinary tract infections: Are there distinct uropathogenic E. coli(UPEC) pathotypes? FEMS Microbiol Lett 2005; 252: 183-90.
[6]Tambekar DH, Dhanorkar DV, Gulhane SR,Khandelwal VK, Dudhane MN. Antibacterial susceptibility of some urinary tract pathogens to commonly used antibiotics. Afr J Biotechnol 2006; 17: 1562-5.
[7]Zhanel GG, Karlowsky JA, Harding GK, Carrie A, Mazzulli T, Low DE, Hoban DJ. Canadian national surveillance study of urinary tract isolates from outpatients: Comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin,mecillinam, nitrofurantoin, and ciprofloxacin.The Canadian urinary isolate study group.Antimicrob Agents Chemother2000; 44: 1089-92.
[8]Ronald NJ. Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: Afive-year summary from the SENTRYantimicrobial surveillance program(1997-2001). Semin Respir Crit Care Med 2003;1: 121-34.
[9]Ibrahim EH, Sherman G, Ward S, Fraser VJ,Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146-55.
[10]Yüksel S, Öztürk B, Kavaz A, Özçakar ZB, Acar B, Güriz H, Aysev D, Ekim M, Yalçinkaya F.Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections. Int J Antimicrob Agents2006; 28: 413-6.
[11]Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacterspecies and Pseudomonasaeruginosa. Clin Infect Dis 2006;43; Suppl 2: 49-56.
[12]Mehrgan H, Rahbar M. Prevalence of extended-spectrum ß-lactamase-producing Escherichia coli in a tertiary care hospital in Tehran, Iran. Int JAntimicrob Agents2008; 31: 147-51.
[13]Kader AA, Angamuthu K. Prevalence and antimicrobial susceptibility of extended-spectrum ß-lactamase-producing Escherichia coli and Klebsiella pneumoniaein a general hospital. Ann Saudi Med2005; 25: 239-42.
- Abstract Viewed: 288 times
- IJPS_Volume 5_Issue 3_Pages 135-140 Downloaded: 171 times